Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by FORA Capital LLC

FORA Capital LLC grew its stake in Henry Schein, Inc. (NASDAQ:HSIC) by 76.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 21,763 shares of the company’s stock after purchasing an additional 9,412 shares during the period. FORA Capital LLC’s holdings in Henry Schein were worth $1,587,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Cromwell Holdings LLC boosted its stake in shares of Henry Schein by 93.4% in the third quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after buying an additional 170 shares in the last quarter. Summit Securities Group LLC purchased a new stake in shares of Henry Schein in the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA purchased a new stake in shares of Henry Schein in the second quarter valued at approximately $37,000. Blue Trust Inc. boosted its stake in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after buying an additional 475 shares in the last quarter. Finally, Farther Finance Advisors LLC boosted its stake in shares of Henry Schein by 58.9% in the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock valued at $68,000 after buying an additional 346 shares in the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of analysts recently weighed in on HSIC shares. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. UBS Group decreased their target price on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Evercore ISI boosted their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Finally, JPMorgan Chase & Co. decreased their target price on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Six research analysts have rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $79.38.

Henry Schein Stock Up 0.5 %

Shares of NASDAQ:HSIC opened at $77.66 on Thursday. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 52-week low of $63.67 and a 52-week high of $82.63. The stock’s fifty day simple moving average is $71.15 and its 200-day simple moving average is $69.78. The company has a market capitalization of $9.68 billion, a P/E ratio of 31.96, a P/E/G ratio of 2.20 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.32 earnings per share. As a group, equities research analysts forecast that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Insider Activity at Henry Schein

In related news, COO Michael S. Ettinger sold 12,240 shares of the company’s stock in a transaction on Monday, November 18th. The stock was sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares in the company, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the company’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.